Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Viva Biotech Holdings ( (HK:1873) ) has issued an update.
Viva Biotech Holdings announced the grant of 8,580,000 share options to 44 eligible employees, who are core members of its CDMO operations. These share options are part of the company’s Post-IPO Share Option Scheme and are subject to performance targets, with vesting dates spread across 2028 to 2030. The grant aims to incentivize employees by aligning their performance with the company’s growth targets, which include significant revenue increases over the next few years. This move is expected to enhance employee commitment and drive the company’s growth in the competitive biotech industry.
The most recent analyst rating on (HK:1873) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Viva Biotech Holdings stock, see the HK:1873 Stock Forecast page.
More about Viva Biotech Holdings
Viva Biotech Holdings operates in the biotechnology industry, focusing on contract development and manufacturing organization (CDMO) services. The company provides drug discovery and development services, catering to the needs of pharmaceutical and biotech companies.
Average Trading Volume: 8,775,924
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.27B
See more data about 1873 stock on TipRanks’ Stock Analysis page.